Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyPOINT
NCT04259970Phase 4Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2020
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of hyperpolarized xenon gas in cystic fibrosis (CF), sponsored by Cincinnati Children's Hospital Medical Center. Started Jan 2020; status: completed.
02
Drugs
hyperpolarized xenon gas
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04259970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04259970.